UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 8, 2016
JRSIS HEALTH CARE CORPORATION
(Exact Name of Registrant as Specified in Charter)
| Florida | 333-194359 | 46-4562047 | ||
| (State or Other Jurisdiction | (Commission File Number) | (IRS Employer | ||
| of Incorporation) | Identification No.) |
1st – 7thFloor, Industrial and Commercial Bank Building, Xingfu Street, Hulan Town, Hulan District, Harbin City, Heilongjiang Province, China 150025 |
| (Address of Principal Executive Offices) (Zip Code) |
| 0086-451-56888933 |
| Registrant’s telephone number, including area code |
| (Former Name or Former Address |
| if Changed Since Last Report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 8.01 Other Events.
As of October 8, 2016, JRSIS Health Care Corporation’s quotation status was upgraded from the OTCBB and its shares of common stock are now being quoted on the OTCQB Marketplace under the trading symbol “JRSS.”
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: October 11, 2016
JRSIS HEALTH CARE CORPORATION
| By: | /s/ Lihua Sun | |
| Name: Lihua Sun | ||
| Title: Chief Executive Officer |
